A global effort led by Monash University has changed the name of a significant women's health condition that was misunderstood to be 'all about ovarian cysts'.

13 May 2026

Home-based assessments may detect early mobility risks

Predicting whether a healthy 45-year-old will struggle to climb stairs or walk a decade later has long been a challenge for geriatric medicine.

12 May 2026

Interactive AI model improves explainable lung cancer diagnosis from CT scans

Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making early and accurate diagnosis essential for improving patient outcomes.

12 May 2026

Why is the US falling behind other high-income nations on survival?

A JAMA Network Open study found that the US recorded 12.7 million excess deaths compared with 17 peer high-income countries between 1999 and 2022. Circulatory and metabolic diseases drove much of the burden, while drug poisonings, alcohol-related deaths, and suicide sharply widened the gap among younger Americans.

12 May 2026

How diabetes could drain $5 trillion from the global economy by 2050

A macroeconomic modelling study across 190 countries and territories estimates that diabetes could reduce global economic output by INT$5.177 trillion between 2021 and 2050. Most projected losses stem from diabetes-related disability and morbidity, with high-income countries facing the largest dollar losses and low- and middle-income countries carrying most of the disease burden.

12 May 2026

Bedfont® Scientific recognized for global growth with SEHTA Awards export shortlist

Bedfont® Scientific Limited, an innovative MedTech company that specialises in designing and manufacturing medical breath analysis devices, is thrilled to have been shortlisted in the Export Achievement category at the Science and Engineering Health Technologies Alliance (SEHTA) Healthcare Business Awards 2026.

From Bedfont® Scientific Ltd 12 May 2026

Johns Hopkins researchers develop life-saving AI for early sepsis detection

An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the FDA, one of the first AI-based medical tools to get clearance.

12 May 2026

BGI Genomics joins HGP2 Rare Disease Alliance to close rare disease care gap in Asia-Pacific

The HGP2 RaDiAnce-APAC initiative enhances rare disease diagnosis and genomic medicine, fostering collaboration for improved health in the Asia-Pacific region.

From BGI Genomics 12 May 2026

Common tuberculosis screening test could predict long-term patient survival

Scientists have long known that the immune system plays a key role in aging. As people age, they have weaker responses to vaccination, greater risks of infection and higher levels of inflammation.

11 May 2026

Why are so many mothers missing diabetes follow-up after childbirth?

A New York City cohort study found that few women with postpartum-onset diabetes received guideline-recommended A1C monitoring over three years. Non-Hispanic Black women and mothers with more children faced lower monitoring rates, while Medicaid coverage was linked to better follow-up.

11 May 2026

Two leading heart risk tools pass a major global test

A multinational Nature Medicine validation study found that PREVENT and SCORE2 cardiovascular risk equations performed generally well across 6.4 million people from observational cohorts and randomized trials. The findings support broader use of these tools for CVD risk stratification, while highlighting the need for local calibration and more validation in underrepresented regions.

11 May 2026

Physician mothers return to work sooner than many Canadian parents, study finds

Ontario physicians increased their workload in the first two trimesters of pregnancy, suggesting many may frontload clinical work before parental leave. Parental leave varied widely by specialty, with surgeons returning earliest and psychiatrists returning latest, highlighting persistent inequities in how medical practice supports childbearing physicians.

11 May 2026

Psychological frameworks help AI models to provide better health care advice

Researchers at Technische Universität Berlin have discovered that teaching Large Language Models (LLMs) to mimic human intuition and reasoning significantly improves their ability to provide accurate medical care-seeking advice.

11 May 2026

Telemedicine has not significantly boosted healthcare costs, study finds

New UCLA-led research finds that use of telemedicine has not significantly increased visits and medical spending across all payer types.

11 May 2026

New certification pathway launches for advanced immune effector cell therapies

JACIE has successfully completed its first-ever inspection under the 3rd Edition Immune Effector Cells (IEC) Standards at Guy's and St Thomas' NHS Foundation Trust - marking a major milestone for the certification of cellular therapy programmes beyond Stem Cell transplantation.

11 May 2026

Qureight establishes Scientific Advisory Board focused on pulmonary hypertension

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has established a Scientific Advisory Board (SAB) focused on pulmonary hypertension (PH).

From Qureight 11 May 2026

Gastrolyzer® interpretation chart update

Included with every Gastrolyzer® range order, Bedfont® Scientific Limited provides practical resources designed to support and simplify hydrogen and methane breath testing (HMBT).

From Bedfont® Scientific Ltd 11 May 2026

Non-invasive swab test offers fast, accurate tuberculosis detection worldwide

A portable molecular test, MiniDock MTB, detected pulmonary tuberculosis rapidly and accurately across seven high-burden countries, using sputum or tongue swab samples. The study suggests the low-cost, battery-operated platform could expand near-point-of-care TB diagnosis in low-resource settings, although real-world implementation and drug-resistance integration still need evaluation.

10 May 2026

Could a fingerprick at home flag your Alzheimer's risk? New study says yes

Researchers demonstrated that self-administered fingerprick blood tests measuring p-tau217 and GFAP, returned by post, correlate strongly with venous blood biomarkers and cognitive performance across the Alzheimer's disease continuum. Combined with computerized cognitive testing, this at-home approach offers a scalable, patient-friendly tool for triaging individuals at risk of AD-related impairment.

10 May 2026